Koyfin Home > Directory > Health Care > Aimmune Therap > Market Cap

Aimmune Therap Market Cap Chart (AIMT)

Aimmune Therap annual/quarterly Market Cap from 2015 to 2020. Market capitalization (market cap) is the market value of a publicly traded company's outstanding shares. Market capitalization is equal to the share price multiplied by the number of shares outstanding.
  • Aimmune Therap Market Cap for the quarter ending October 10, 2020 was $2,268m a 0.00% decrease of 0m year over year
  • Aimmune Therap Market Cap for the last 12 months ending October 10, 2020 was $2,268m a 0.00% decrease of 0m year over year
  • Aimmune Therap Annual Market Cap for 2020 was $2,268m a 0.00% decrease of 0m from 2019
  • Aimmune Therap Annual Market Cap for 2020 was $2,268m a 0.00% decrease of 0m from 2019
  • Aimmune Therap Annual Market Cap for 2020 was $2,268m a 0.00% decrease of 0m from 2019
Other Valuation Metrics:
  • Aimmune Therap Price / Book for the quarter ending March 03, 2018 was 9.15 a 57.27% increase of 5.24 year over year
  • Aimmune Therap Enterprise Value for the quarter ending March 03, 2018 was $1,659m a 52.45% increase of 870m year over year
View Chart On Koyfin

Quarterly AIMT Market Cap Data

10/2020$2,268m
10/2020$2,268m
10/2020$2,268m
10/2020$2,268m
10/2020$2,268m
10/2020$2,268m
10/2020$2,268m
10/2020$2,275m
10/2020$2,264m
10/2020$2,264m

Annual AIMT Market Cap Data

2020$2,268m
2020$2,268m
2020$2,268m
2020$2,268m
2020$2,268m
2020$2,268m
2020$2,268m
2020$2,275m
2020$2,264m
2020$2,264m